Description

LIPOBREC-180 Tablets

 

• A novel nonstain drug that inhibits cholesterol biosynthesis in the same pathway as stains and helps in the treatment of hypercholesterolemia.
• Clinical studies have demonstrated promising results regarding its safety and efficacy either as monotherapy or in combination with stains or ezetimibe among different patient profiles
• well tolerated in the treatment of hyperlipidemia and cardiovascular diseases like unstable angina, coronary revascularization, coronary heart disease Diagnosed, and peripheral arterial disease

• In the lear harmony (fig 2) and clear wisdom trials (fig 1) bempedoic acid {lipobrec} added to stain therapy did not increase overall adverse events than placebo and led to significantly lower LDL cholesterol levels,
  

• It is well-tolerated, easily absorbed, and has an excellent safety profile
  

           A safe alternative to statins

unlike statins, it is administered as a prodrug and is converted to active forms by enzymes found only in the liver & not in muscles, making it a promising alternative for patients with stain-associated muscle symptoms